Holdings Information

Bibliographic Record Display

• Title:Dx/Rx : colorectal cancer / Kyle Holen, Ki Young Chung.
  
•    
• Variant Title:Colorectal cancer
  
• Author/Creator:Holen, Kyle.
  
• Other Contributors/Collections:Chung, Ki Young.
  
• Published/Created:Sudbury, Mass. : Jones and Bartlett Publishers, ©2008.
  

• Holdings

  Holdings Record Display

  • Location:WOODWARD LIBRARY stacksWhere is this?
    
  • Call Number: WI529 .H729 2008
    
  • Number of Items:1
    
  • Status:Available
    

   
• Medical Subjects:Colorectal Neoplasms--therapy.
  
• Description:xi, 81 p. : ill. ; 21 cm.
  
• Series:Jones and Bartlett Publishers Dx/Rx oncology series.
  
• Notes:Includes bibliographical references and index.
  
• ISBN:9780763747442 (alk. paper)
  0763747440
  
• Contents:1. Epidemiology
  Incidence and Mortality
  Etiology and Risk Factors
  Diet
  Genetic Factors
  Physical Activity
  Inflammatory Bowel Disease
  Other risk factors
  2. Prevention and Screening
  Chemoprevention
  Screening
  3. Pathology, Staging, and Prognosis
  Pathology
  TNM Staging and Dukes Staging
  4. Early Stage Treatment
  Stage I
  Stage II
  Select Randomized Stage II Colon Cancer Trials
  Stage II CRC Adjuvant Epidemiologic Evaluations
  Stage II CRC Adjuvant Trial Meta-analyses
  ASCO and NCCN Guidelines
  Other High-Risk Features of Colon Cancer That Require Further Prospective Evaluation
  New Trials for Stage II Colon Cancer
  5. Stage III Treatment and Surveillance
  Chemotherapy Rationale
  Single Agent Fluoropyrimidines
  Advanced 5-FU-Based Combination Chemotherapy Regimens
  Oxaliplatin-Based Adjuvant Therapy
  Irinotecan-Based Adjuvant Therapy
  DFS is an Appropriate Endpoint for Adjuvant Studies
  Molecular Markers
  Integration of Targeted Agents into Clinical Trials
  New Adjuvant Trials for Stage III Colon Cancer
  6. Oligometastatic Disease: Surgical and Regional Approach
  Surgery
  Hepatic Artery Infusion
  Adjuvant Therapy After Resection of Hepatic Metastases
  HAI Chemotherapy in Unresectable Liver-Only Metastatic CRC Patients
  Randomized Trials
  7. Chemotherapy
  Fluorouracil
  Capecitabine
  Irinotecan
  Oxaliplatin
  Cetuximab
  Bevacizumab
  Panitumumab (Vectibix)
  Combinations of Biologic Therapy
  First-Line Chemotherapy
  Second-Line and Third-Line Chemotherapy
  Novel Agents in Colorectal Cancer
  8. Management Issues Specific to Rectal Cancer
  Surgery
  Chemotherapy
  Radiation.